Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Dec 03, 2021 10:29am
152 Views
Post# 34194571

RE:RE:By and large

RE:RE:By and large

the 50 cents was reffering to a market cap requirement for listing on the NASDAQ and had nothing to do with the rollback. All he was saying was that with the amount of shares we have out today we would need to hit 55 cents in order to qualify for a listin, as opposed to before the financing where we had the required MC at 70 ish cents. Price x shares out = MC. Off the top of my head I think it's $100M. 

They must be aware that a part of the "price problem" is the overhang from of a potential rollback itself. For the most part, once you roll back, you take a huge hit to the share price. It's just the way that it is. Unless you have a good marketing campaign, a good sponsor or some noteworthy news to prop the price. So I wish they would just do it instead of talking about it. I could see a lot of smart money sitting on the sidelines and not touching the story thinking "I'll wait until they roll it back and get a better price". 


daviking wrote: Tech, you said," Not sure about the reverse split part since he was also referring to shae price of 0.50 + so I don't quite know what he was talking about.."
I'm nost sure but my view is that with the minimum quantity, 10 for 1, that would get the SP to $5. zminimum zdp got Nasdaq has been bandied about  in many different companies I've followed, but if $2 or $4 would be cover that requirement (if they have follow up "announcements " to solidify that price.
10/1 gives EDT 25-28M shares. I'm not sure why they would do a higher rate, like 15/1 or 20/1 as that is the highest number they gave in the prospectus, I believe.

 

<< Previous
Bullboard Posts
Next >>